GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation
GC Biopharma has developed a technology platform capable of precisely analyzing how mRNA vaccines degrade when exposed to temperature fluctuations,...
Search results for "Pharmaceutical Research"
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion
Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan. By combining the foundational research and technical...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Dongkook Pharmaceutical Launches PDRN-Infused Lightweight Moisturizer
Dongkook Pharmaceutical has expanded its skincare portfolio with a new moisturizing cream that incorporates...
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports
GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage
Pharmacies in South Korea will no longer be allowed to use terms that evoke a “warehouse” or “factory” on their...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide
It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.